# A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.

> **NCT07575906** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 8 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-08057418
- **OTHER:** Placebo (A placebo does not have any medicine in it but looks just like the medicine being studied.)

## Key facts

- **NCT ID:** NCT07575906
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-08
- **Primary completion:** 2026-07-23
- **Final completion:** 2026-07-23
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07575906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07575906, "A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT07575906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*